Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Healthcare Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Sirona Biochem Corp > Failed - Without Shame or Explanation or Communication
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(52)
•••
Post by bealerton Mar 19, 2024 1:16pm
157 Views
Post# 35940984

Failed - Without Shame or Explanation or Communication

Failed - Without Shame or Explanation or CommunicationSleepy Howard, you are correct with the "FAILED" title.

Last trade  so far today at 6.5 cents by some Jerk at Scotia.  Hope they had a good reason.  No sign of a turnaround, just doldrums.

I get sick looking at that smile(smirk) on the website so I stay away as much as possible.  If you had him as your business manager, you might as well close the door before you opened your business

Supposedly we are on the verge of a breakout early next year???  How do we believe this when there is ZERO momentum with the share price.  I think we have been had again! .

And the PP?  W T F is going on with that?  Can't find more suckers?

TOTALLY DISILLUSIONED BEALERT
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities